⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloromethane SCHEMBL1814391 | 0.89 | — | — | |
| Ethane SCHEMBL108080 | 0.81 | — | — | |
| SCHEMBL102156 | 0.80 | — | — | |
| SCHEMBL5078402 | 0.77 | — | — | |
| Methane SCHEMBL204080 | 0.76 | — | — | |
| SCHEMBL28559195 | 0.76 | — | — | |
| Isobutane SCHEMBL454297 | 0.74 | — | — | |
| Propane SCHEMBL1420935 | 0.74 | — | — | |
| Ethylene SCHEMBL6849353 | 0.72 | — | — | |
| Butane SCHEMBL583590 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788349-A1 | KINASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2014-10-15 | — | — | EP | disclosed |
| EP-2788348-A1 | KINASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2014-10-15 | — | — | EP | disclosed |
| US-8609659-B2 | Substituted 3,8-diazabicyclo[3.2.1]octane compounds | NEUROSCIENZE PHARMANESS S.C.A.R.L. (IT) | 2013-12-17 | — | — | US | disclosed |
| WO-2013083604-A1 | KINASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013083606-A1 | KINASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-06-13 | — | — | WO | disclosed |
| EP-2338889-B1 | Diazacyclic compounds having affinity for opioid receptors | NEUROSCIENZE PHARMANESS S C A R L (IT) | 2012-08-29 | — | — | EP | disclosed |
| EP-2338889-A1 | Diazacyclic compounds having affinity for opioid receptors | Neuroscienze Pharmaness S.C. A R.L. (IT) | 2011-06-29 | — | — | EP | disclosed |
| US-20110152238-A1 | PHARMACEUTICAL COMPOUNDS | NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) | 2011-06-23 | — | — | US | disclosed |
| WO-2008072078-A1 | AN IMPROVED PROCESS FOR PREPARING ROSUVASTATIN CACLIUM | AUROBINDO PHARMA LIMITED (IN) | 2008-06-19 | — | — | WO | disclosed |
| WO-2007142810-A2 | METHODS OF USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP | SOMAXON PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | WO | disclosed |
| EP-0931062-A1 | CONJUGATES AND SPECIFIC IMMUNOASSAYS FOR THE METHADONE METABOLITE 2-ETHYLIDINE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE | MICROGENICS CORPORATION (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1998054133-A1 | CONJUGATES AND SPECIFIC IMMUNOASSAYS FOR THE METHADONE METABOLITE 2-ETHYLIDINE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE | MICROGENICS CORPORATION (US) | 1998-12-03 | — | — | WO | disclosed |
| EP-0400916-A2 | 4,5,6,11-Tetrahydrobenzo [6,7]-cycloocta[1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11 imines | PFIZER INC. (US) | 1990-12-05 | — | — | EP | disclosed |